MUN/5VA (MUN/5VA)

Munich Stock Exchange: MUN/5VA · EUR

€54.0

+0.00 (0.0%)· Recorded snapshot

Market cap	8.6B
Net income (ttm)	-931.5M
EPS (ttm)	-€6.88
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -931.5M
EPS (ttm): -€6.88
Market cap: 8.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.5P50 19.1P75 28.3

Trailing P/En/a

P25 14.1P50 23.7P75 38.5

ROE-36.5

P25 -50.4P50 0.5P75 12

ROIC-24.2

P25 -29.8P50 1.9P75 10.7

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All MUN/5VA indicators

Market & fundamental data

Available fields

143

Groups with data

Currency

USD

Showing 143 of 143 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-11-04
Employees	507
Employees change	93
Employees growth	22.46%
Enterprise value	EUR 7.3B
Exchange	Munich Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2013
Industry	Biotechnology
Is primary listing	No
ISIN number	US92243G1085
Last earnings date	2026-02-24
Last refreshed	2026-10-28
Market cap	EUR 8.6B
Next earnings date	2026-11-04
Price	EUR 54.00
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	mun/5VA
Website	https://vaxcyte.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-12.73%
FCF / EV yield	-10.98%
FCF yield	-9.41%
P/B ratio	3.55x
Price / tangible book value	3.55x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	EUR -1.8M
ROA	-22.61%
ROA (5Y)	-19.26%
ROCE	-40.65%
ROE	-36.51%
ROE (5Y)	-30.11%
ROIC	-24.15%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -34.9M
Depreciation and amortization	EUR 14.8M
EBIT	EUR -1B
EBITDA	EUR -1B
EPS	EUR -6.88
Financing cash flow	EUR 530.5M
Free cash flow	EUR -806.2M
Free cash flow minus SBC	EUR -938M
Investing cash flow	EUR 131.8M
Net cash flow	EUR -108M
Net income	EUR -931.5M
Operating cash flow minus SBC	EUR -903.1M
Operating income	EUR -1B
Stock-based compensation	EUR 131.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 16.67
Debt / equity	0.04
Long-term assets	EUR 1.4B
Long-term liabilities	EUR 88.9M
Net cash (debt)	EUR 1.2B
Net cash / market cap	14.01%
Net cash growth	-12.96%
Net debt / equity	-0.5
Piotroski F-Score	1
Property, plant and equipment	EUR 333.2M
Shareholders' equity	EUR 2.4B
Tangible book value	EUR 2.4B
Tangible book value per share	EUR 16.67
Total assets	EUR 2.7B
Total cash	EUR 1.3B
Total debt	EUR 101M
Total liabilities	EUR 332.8M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	EUR 1.4B
Current liabilities	EUR 243.9M
Current ratio	5.72
Net working capital	EUR -174.1M
Quick ratio	5.48
Working capital	EUR 1.1B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-4.88%
Shareholder yield	-4.88%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 28.58
1D price change	0%
1M price change	4.85%
1M total return	4.85%
1W price change	25%
1W total return	25%
1Y price change	100%
1Y return CAGR	100.1%
1Y total return	100%
20-day SMA	EUR 46.70
200-day SMA	EUR 29.53
3M price change	35%
3M total return	35%
50-day SMA	EUR 47.91
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 54.00
52-week high date	2026-10-26
52-week low	EUR 25.80
52-week low date	2025-08-12
5Y price change	217.65%
5Y return CAGR	26.01%
5Y total return	217.65%
6M price change	56.07%
6M total return	56.07%
All-time high	EUR 100.00
All-time high date	2024-09-06
All-time low	EUR 13.60
All-time low date	2021-05-11
Average true range (ATR)	EUR 5.53
Average volume	158.2
Change from 52-week high	0%
Change from 52-week low	109.3%
Change from all-time high	-46%
Change from all-time low	297.06%
Change from open	0%
Day's gap	0%
High price	EUR 54.00
Low price	EUR 54.00
Monthly RSI	49.98
Open price	EUR 54.00
Previous close	EUR 54.00
Price vs 150-day SMA	88.96%
Price vs 20-day SMA	15.63%
Price vs 200-day SMA	82.9%
Price vs 50-day SMA	12.72%
Relative volume	0.73
RSI	48.06
Sharpe ratio	0.87
Sortino ratio	1.78
Volume	0
Weekly RSI	50.29
YTD price change	37.06%
YTD total return	37.06%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	145M
Shares change (QoQ)	3.58%
Shares change (YoY)	4.88%
Shares held by insiders	0.59%
Shares held by institutions	100.38%
Short ratio	7.2 days

Deeper analysis on MUN/5VA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MUN/5VA report

Is a complete MUN/5VA research report available?

No complete published report is available for mun/5VA (MUN/5VA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

MUN/5VA (MUN/5VA)

Price

Financial snapshot

Fair-value bridge

Latest news · MUN/5VA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MUN/5VA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MUN/5VA

Frequently asked questions